As such, the completeness and follow-up of data are dependent on the source data quality and consistency
Obesity pharmacotherapy, such as GLP-1 receptor agonists, is often necessary for long-term weight management, and stopping these medications frequently results in weight regain
And weight loss from the medications, while impressive, wont, on its own, make heavy people thin
The following protocols are designed for three distinct populations and provide specific, actionable programming that you can implement immediately
Patients typically begin to see weight loss results within a few weeks of starting treatment with either Ozempic or Wegovy, with more significant and sustained weight reduction observed over several months (e.g., 68 weeks in clinical trials for Wegovy)
However, while the initial findings suggest beneficial outcomes, there remains a pressing need for further research to better understand the long-term effects of semaglutide in this specific population